Gsa Capital Partners LLP Biodesix Inc Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Biodesix Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 931,394 shares of BDSX stock, worth $381,871. This represents 0.02% of its overall portfolio holdings.
Number of Shares
931,394
Previous 33,335
2694.04%
Holding current value
$381,871
Previous $21,000
1152.38%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BDSX
# of Institutions
63Shares Held
47.8MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$3.4 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$2.5 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$2.35 Million3.25% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.68 Million0.63% of portfolio
-
Monashee Investment Management LLC Boston, MA4.05MShares$1.66 Million0.35% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $16.4M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...